Want to see QTI full AI Analyst Report?
QTI Stock Chart & Stats
$3.17
--
Market closed
$3.17
--
Day’s Range― - ―
52-Week Range$2.42 - $8.50
Previous CloseN/A
VolumeN/A
Average Volume (3M)30.44K
Market Cap
$37.76M
Enterprise Value$65.12
Total Cash (Recent Filing)$10.97M
Total Debt (Recent Filing)$4.33M
Price to Earnings (P/E)―
Beta-0.08
Next Earnings
Nov 17, 2026EPS Estimate
-0.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.17
Shares Outstanding14,636,524
10 Day Avg. Volume29,974
30 Day Avg. Volume30,441
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)9.92
Price to Sales (P/S)3.38
P/FCF Ratio-7.04
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price Target
$10.00Price Target Upside215.46% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)-0.53
Revenue Forecast (FY)$39.20M
Bulls Say, Bears Say
Bulls Say
Accelerating Revenue GrowthRapid revenue and shipment growth indicates that QT Imaging is moving from early commercialization toward broader adoption of its breast imaging platform. If sustained, the expanding installed base can support greater operating leverage, stronger customer reference value, and improved earnings potential over the next several quarters.
Reimbursement And Clinical ProgressReimbursement infrastructure and growing clinical evidence strengthen the pathway from product interest to routine use. The CPT code supports standardized reporting and evidence collection, while real-world imaging volume and reproducibility data can improve physician confidence and facilitate adoption in dense-breast assessment.
Expanded Manufacturing CapacityA substantially larger facility provides room to expand manufacturing capacity as scanner shipments increase, while the lower lease cost per square foot improves the efficiency of the operating footprint. This investment may help QT Imaging support commercialization without proportionally increasing facility costs.
Bears Say
Persistent Heavy LossesQT Imaging has not yet reached the scale needed to cover operating costs, and losses remain substantial relative to revenue. Continued unprofitability can restrict internally funded investment, increase reliance on financing, and make the business more sensitive to delays in customer adoption or shipment growth.
Cash Burn And Rising LeverageNegative operating and free cash flow show that growth is currently consuming cash rather than generating it. Combined with a thinner equity base and materially higher debt-to-equity, this reduces financial flexibility and leaves QT Imaging more dependent on external capital to sustain operations and expansion.
Margin And Execution PressureLower gross margin and rapidly rising operating expenses indicate that commercial expansion is not yet translating efficiently into profitability. Slower customer-site implementation and utilization could delay recurring benefits from the installed base, prolonging the period of elevated spending and operating losses.
QT Imaging Holdings News
QTI FAQ
What was QT Imaging Holdings’s price range in the past 12 months?
QT Imaging Holdings lowest stock price was $2.42 and its highest was $8.50 in the past 12 months.
What is QT Imaging Holdings’s market cap?
QT Imaging Holdings’s market cap is $37.76M.
When is QT Imaging Holdings’s upcoming earnings report date?
QT Imaging Holdings’s upcoming earnings report date is Nov 17, 2026 which is in 47 days.
How were QT Imaging Holdings’s earnings last quarter?
QT Imaging Holdings released its earnings results on Aug 12, 2026. The company reported -$0.75 earnings per share for the quarter, missing the consensus estimate of -$0.22 by -$0.53.
Is QT Imaging Holdings overvalued?
According to Wall Street analysts QT Imaging Holdings’s price is currently Undervalued.
Does QT Imaging Holdings pay dividends?
QT Imaging Holdings does not currently pay dividends.
What is QT Imaging Holdings’s EPS estimate?
QT Imaging Holdings’s EPS estimate is -0.1.
How many shares outstanding does QT Imaging Holdings have?
QT Imaging Holdings has 14,636,524 shares outstanding.
What happened to QT Imaging Holdings’s price movement after its last earnings report?
QT Imaging Holdings reported an EPS of -$0.75 in its last earnings report, missing expectations of -$0.22. Following the earnings report the stock price went down -5.316%.
Which hedge fund is a major shareholder of QT Imaging Holdings?
Currently, no hedge funds are holding shares in QTI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
QT Imaging Holdings Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$10.00 (215.46% Upside)
$10.00 (215.46% Upside)
Hedge Fund Trend
Decreased
By 66.1K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Negative
20 days / 200 days
Momentum
-64.12%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
163.33%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
QT Imaging Holdings
QT Imaging Holdings, Inc. is dedicated to the research, development, and manufacturing of advanced automated systems for breast imaging. These innovative devices are engineered to generate high-resolution ultrasound images utilizing transmission technology. The company's core product, the QT Ultrasound Breast Scanner, offers comprehensive reflection-mode and transmission-mode visualization of a patient's breast tissue. Established in 2011, QT Imaging Holdings, Inc. maintains its headquarters in Novato, California.
QTI Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call signals a positive commercial and clinical momentum: strong top-line growth with shipments and revenue more than doubling year-over-year, meaningful regulatory and reimbursement progress (Category III CPT code and international clearances), reproducibility and clinical study progress, product and manufacturing investments, and improved near-term liquidity. Offsetting these positives are margin compression, higher operating expenses, a materially larger net loss driven by an $8.3M non-cash debt modification charge, higher interest costs on amended debt, and some regional/geopolitical and deployment timing headwinds. Many of the negative items appear one-time or transitional (debt modification, upfront investment in commercial infrastructure, timing of deployments), while several strategic enablers (CPT code, clinical data, manufacturing expansion) support a constructive growth outlook.View all QTI earnings summariesQTI Stock 12 Month Forecast
Average Price Target
$10.00
▲(215.46% Upside)
Technical Analysis
Ownership Overview
14.28% Insiders
0.16% Mutual Funds
16.55% Other Institutional Investors
66.37% Public Companies and
Individual Investors